{"metadata": {"organization_names": [], "person_names_verified": ["kevin insley", "stephen m. simes"], "organization_names_verified": ["bpa and company", "bpa, company", "clarendon house"], "vars": {"Party": {"Azur Pharma International II Limited": "[[Party 2]]", "BioSante Pharmaceuticals, Inc.": "[[Party 1]]"}}, "entities_rejected": ["xxxxxxxx milestone"], "person_names": [], "agreement_id": "eb95b281d53c0a8179579bd29a6b5b5ae0188ac0aa54f716728850abea0adef0", "topics": [], "terms": ["**AMENDMENT NO. 1 TO LICENSE AGREEMENT**", "**AND ASSET PURCHASE AGREEMENT**", "**After**", "**Current**", "**Event**", "**Payment One**", "**Payment Three A**", "**Payment Three**", "**Payment Two A**", "**Payment Two**", "**[Portions of this Exhibit have been omitted pursuant to a request for confidentiality under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A copy of this Exhibit with all sections intact has been filed separately with the Securities and Exchange Commission.]**", "**[Portions of this Section have been omitted pursuant to a request for confidentiality under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A copy of this Exhibit with all sections intact has been filed separately with the Securities and Exchange Commission.]**", "*[signature page follows]*", "*provided, however*", "\u201c**Amendment Effective Date**\u201d", "\u201c**Amendment**\u201d", "\u201c**Asset Purchase Agreement**\u201d", "\u201c**BPA**\u201d", "\u201c**Company**\u201d", "\u201c**Infringement Claim**\u201d", "\u201c**Infringement Suit**\u201d", "\u201c**License Agreement**\u201d", "\u201c**Parties**\u201d", "\u201c**Party**\u201d", "\u201c**Payment One**\u201d", "\u201c**Payment Three A**\u201d", "\u201c**Payment Three**\u201d", "\u201c**Payment Two A**\u201d", "\u201c**Payment Two**\u201d", "\u201cIn the event that one of more generic versions. . . .\u201d"]}}